Contineum Therapeutics (CTNM) Other Non-Current Assets (2023 - 2026)
Contineum Therapeutics (CTNM) posted quarterly Other Non-Current Assets of $364000.0 for Q2 2026, up 95.7% year-over-year from $186000.0 in Q2 2025, and up 16.67% quarter-over-quarter from $312000.0 in Q1 2026.
Contineum Therapeutics (CTNM) Other Non-Current Assets (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $364000.0 for Q2 2026.
- In Q2 2026, Other Non-Current Assets rose 95.7% year-over-year to $364000.0; the TTM figure through Jun 2026 stood at $364000.0 (up 95.7% YoY), while the FY2025 annual figure was $256000.0, up 8433.33% from the prior year.
- Other Non-Current Assets for Q2 2026 stood at $364000.0, up from $312000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $2.6 million in Q1 2024, with the low at $3000.0 in Q2 2024.
- The 4-year median for Other Non-Current Assets is $256000.0 (2025), against an average of $482090.9.
- Peak annual rise in Other Non-Current Assets reached 8766.67% in 2025, while the deepest fall reached 99.85% in 2025.
- Contineum Therapeutics' Other Non-Current Assets stood at $1.3 million in 2023, then plunged by 99.77% to $3000.0 in 2024, then soared by 8433.33% to $256000.0 in 2025, then surged by 42.19% to $364000.0 in 2026.
- Business Quant data shows CTNM's Other Non-Current Assets at $364000.0 in Q2 2026, $312000.0 in Q1 2026, and $256000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Contineum Therapeutics | 533.73 Mn | 533.73 Mn | - | 364,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 364,000.00 |
| Mar 31, 2026 | 312,000.00 |
| Dec 31, 2025 | 256,000.00 |
| Sep 30, 2025 | 266,000.00 |
| Jun 30, 2025 | 186,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 2.62 Mn |
| Dec 31, 2023 | 1.28 Mn |